ArticleTherapeutic advances in hematology2025

Real-world survival, cognitive, and quality of life outcomes of methotrexate/ifosfamide plus whole brain radiotherapy for newly diagnosed primary central nervous system lymphoma.

Warayoot Luangmaneerote et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.